[Prostate carcinoma: determination of progression following high-voltage therapy (author's transl)]. 1977

C E Alken, and G Dhom, and D B Kopper, and H Rehker, and R Dietz, and S Kopp, and M Ziegler

The fourth report of our long-term study concerns 70 cases of primary radiotherapy. The side effects of our radiation technique are minimal and temporary; in over 80% of the cases, potency was not affected. The morphologically demonstrable changes in the tumor tissue, in the original glandular parenchyma, and in the fibromuscular stroma leading to the vessels following high-voltage therapy are described. Three types of progressive patterns, based on the grade of histologic regression, can be determined. In more than half of the cases, with increasing distance from the source of radiation, no tumor or only minimal residual tumor was demonstrable. Sensibility and resistance of carcinoma of the prostate are not dependent upon the grade of differentiation of the tumor. A prognostic statement concerning the success of radiation therapy from initial histologic findings is not possible here. The occurrence of metastases in 18% of the cases following radiation probably resulted from the inexactness of the purely clinical determination of the stage of the tumor. The isolated, local treatment of prostate carcinoma through radiotherapy is justified only after exact determination of the stage of the tumor, i.e., certain exclusion of metastases via a diagnostic lymphadenectomy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D011882 Radiotherapy, High-Energy Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle. Megavolt Radiotherapy,High-Energy Radiotherapy,Radiotherapy, Megavolt,High Energy Radiotherapy,Radiotherapy, High Energy
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D003037 Cobalt Radioisotopes Unstable isotopes of cobalt that decay or disintegrate emitting radiation. Co atoms with atomic weights of 54-64, except 59, are radioactive cobalt isotopes. Radioisotopes, Cobalt
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

C E Alken, and G Dhom, and D B Kopper, and H Rehker, and R Dietz, and S Kopp, and M Ziegler
September 1973, Der Urologe. Ausg. A,
C E Alken, and G Dhom, and D B Kopper, and H Rehker, and R Dietz, and S Kopp, and M Ziegler
July 1979, Wiener medizinische Wochenschrift (1946),
C E Alken, and G Dhom, and D B Kopper, and H Rehker, and R Dietz, and S Kopp, and M Ziegler
June 1981, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
C E Alken, and G Dhom, and D B Kopper, and H Rehker, and R Dietz, and S Kopp, and M Ziegler
January 1980, Radiobiologia, radiotherapia,
C E Alken, and G Dhom, and D B Kopper, and H Rehker, and R Dietz, and S Kopp, and M Ziegler
November 1981, Kokyu to junkan. Respiration & circulation,
C E Alken, and G Dhom, and D B Kopper, and H Rehker, and R Dietz, and S Kopp, and M Ziegler
April 1977, Rontgen-Blatter; Zeitschrift fur Rontgen-Technik und medizinisch-wissenschaftliche Photographie,
C E Alken, and G Dhom, and D B Kopper, and H Rehker, and R Dietz, and S Kopp, and M Ziegler
January 1979, Zentralblatt fur Chirurgie,
C E Alken, and G Dhom, and D B Kopper, and H Rehker, and R Dietz, and S Kopp, and M Ziegler
July 1974, Der Urologe. Ausg. A,
C E Alken, and G Dhom, and D B Kopper, and H Rehker, and R Dietz, and S Kopp, and M Ziegler
December 1983, Zeitschrift fur Urologie und Nephrologie,
C E Alken, and G Dhom, and D B Kopper, and H Rehker, and R Dietz, and S Kopp, and M Ziegler
December 1978, Strahlentherapie,
Copied contents to your clipboard!